Dipal Doshi - CEO, Director at Entrada Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
CEO, Director
Stock Symbol
TRDA on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Dipal Doshi since 11/23/2024

Holdings reported by Dipal Doshi for Entrada Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 416K $2.26M $5.43 Sep 2, 2025 Direct
Stock Option (Right to Buy) 173K Mar 1, 2025 Direct Common Stock

Transactions reported by Dipal Doshi for Entrada Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.